Hochuekkito, a Kampo (Traditional Japanese Herbal) medicine, and its polysaccharide portion stimulate G-CSF secretion from intestinal epithelial cells

Evidence-based Complementary and Alternative Medicine

Volumn 7, Issue 3, 2010, Pages 331-340

  Matsumoto, Tsukasa ^a   Moriya, Michiyo ^a   Kiyohara, Hiroaki ^a   Tabuchi, Yoshiaki ^b   Yamada, Haruki ^a  

^a KITASATO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

G CSF; Hochuekkito; intestinal epithelial cell; Kampo medicines; MCE301 cell; polysaccharide

Indexed keywords

BU ZHONG YI QI TANG; CARBOHYDRATE DERIVATIVE; GRANULOCYTE COLONY STIMULATING FACTOR; KAMPO; PERIODATE; POLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DEGRADATION; DOSE TIME EFFECT RELATION; FEMALE; GENETIC TRANSCRIPTION; IMMUNOMODULATION; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 77953813545     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nen007     Document Type: Article

References (48)

1. Cho JM, Sato N, Kikuchi K. Prophylactic antitumor effect of Hochu-ekki-to (TJ-41) by enhancing natural killer cell activity. In vivo 1991;5:389-392
2. Kataoka T, Akagawa KS, Tokunaga T, Nagao S. Activation of macrophages with Hochu-ekki-to. Jpn J Cancer Chemother 1989;16:1490-1493
3. Mori K, Kido T, Daikuhara H, Sakakibara I, Sakata T, Shimizu K, et al. Effect of Hochu-ekki-to (TJ-41), a Japanese herbal medicine, on the survival of mice infected with influenza virus. Antiviral Res 1999;44:103-111
4. Kiyohara H, Nagai T, Munakata K, Nonaka K, Hanawa T, Kim SJ, et al. Stimulating effect of Japanese herbal (kampo) medicine, hochuekkito on upper respiratory mucosal immune system. Evid Based Complement Alternat Med 2006;3:459-467
5. Matsumoto T, Noguchi M, Hayashi O, Makino K, Hochuekkito YH. A Kampo (traditional Japanese herbal) medicine, enhances mucosal IgA antibody response in mice immunized with antigen-entrapped biodegradable microparticles. Evid Based Complement Alternat Med; doi:10.1093/ecam/nem166.
6. McNabb PC. Host defense mechanisms at mucosal surfaces. Ann Rev Microbiol 1981;35:477-496
7. Fujii Y, Shimada T, Koike T, Hosaka K, Tabei K, Namatame T, et al. Review article: regulation of TFF1 (pS2) expression in gastric epithelial cells. Aliment Pharmacol Ther 2006;24 (Suppl 4): 285-291
8. Andoh A, Fujiyama Y, Sakumoto H, Uchihara H, Kimura T, Koyama S, et al. Detection of complement C3 and factor B gene expression in normal colorectal mucosa, adenomas and carcinomas. Clin Exp Immunol 1998;111:477-483
9. Cunliffe RN. Alpha-defensins in the gastrointestinal tract. Mol Immunol 2003;40:463-467
10. Berin MC, McKay DM, Perdue MH. Immune-epithelial interactions in host defense. Am J Trop Med Hyg 1999;60 (4 Suppl): 16-25.
11. Blumberg RS, Terhorst C, Bleicher P, McDermott FV, Allan CH, Landau SB, et al. Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells. J Immunol 1991;147:2518-2524
12. Agace WW, Higgins JM, Sadasivan B, Brenner MB, Parker CM. T-lymphocyte-epithelial-cell interactions: integrin aE(CD103)b7, LEEP-CAM and chemokines. Curr Opin Cell Biol 2000;12:563-568
13. Brandtzaeg P, Prydz H. Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins. Nature 1984;311:71-73
14. Balkwill FR, Burke F. The cytokine network. Immunol Today 1989;10:299-304.
15. Bellanti JA, Kadlec JV, Escobar-Gutierrez A. Cytokines and the immune response. Pediatr Clin North Am 1994;41:597-621.
16. Liles WC, Van Voorhis WC. Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J Infect Dis 1995;172:1573-1580
17. Tabuchi Y, Ohta S, Arai Y, Kawahara M, Ishibashi K, Sugiyama N, et al. Establishment and characterization of a colonic epithelial cell line MCE301 from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene. Cell Struct Funct 2000;25:297-307.
18. Baumgart DC, Olivier WA, Reya T, Peritt D, Rombeau JL, Carding SR. Mechanisms of intestinal epithelial cell injury and colitis in interleukin 2 (IL2)-deficient mice. Cell Immunol 1998;187:52-66.
19. Yamada H, Kiyohara H, Cyong JC, Takemoto N, Komatsu Y, Kawamura H, et al. Fractionation and characterization of mitogenic and anti-complementary active fractions from kampo (Japanese Herbal) medicine ''juzen-taiho-to''. Planta Med 1990;56:386-391
20. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956;28:350-356
21. Blumenkranz N, Hansen GA. New method for quantative determination of uronic acid. Anal Biochem 1973;54:484-489
22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976;72:248-254
23. York WS, Darvill AG, McNeil M, Stevenson TT, Albersheim P. Isolation and characterization of plant cell walls and cell-wall components. Methods Enzymol 1985;118:3-40.
24. Sallerfors B. Endogenous production and peripheral blood levels of granulocyte-macrophage (GM-) and granulocyte (G-) colonystimulating factors. Leuk Lymphoma 1994;13:235-247
25. Calatayud S, Warner TD, Breese EJ, Mitchell JA. Relationship between endogenous colony stimulating factors and apoptosis in human colon cancer cells: role of cyclo-oxygenase inhibitors. Br J Pharmacol 2001;134:1237-1244
26. Nishizawa M, Nagata S. Regulatory elements responsible for inducible expression of the granulocyte colony-stimulating factor gene in macrophages. Mol Cell Biol 1990;10:2002-2011
27. Lehne G, Haneberg B, Gaustad P, Johansen PW, Preus H, Abrahamsen TG. Oral administration of a new soluble branched beta-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers. Clin Exp Immunol 2006;143:65-69
28. Yamaoka Y, Kawakita T, Kaneko M, Nomoto K. A polysaccharide fraction of Zizyphi fructus in augmenting natural killer activity by oral administration. Biol Pharm Bull 1996;19:936-939
29. Kim HY, Kim JH, Yang SB, Hong SG, Lee SA, Hwang SJ, et al. A polysaccharide extracted from rice bran fermented with Lentinus edodes enhances natural killer cell activity and exhibits anticancer effects. J Med Food 2007;10:25-31.
30. Yin Y, Fu W, Fu M, He G, Traore L. The immune effects of edible fungus polysaccharides compounds in mice. Asia Pac J Clin Nutr 2007;16 (Suppl 1): 258-260
31. Kelly GS. Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysaccharide. Altern Med Rev 1999;4:96-103.
32. Lorentsen KJ, Hendrix CW, Collins JM, Kornhauser DM, Petty BG, Klecker RW, et al. Dextran sulfate is poorly absorbed after oral administration. Ann Intern Med 1989;111:561-566
33. Tsuchiya M, Asano S, Kaziro Y, Nagata S. Isolation and characterization of the cDNA for murine granulocyte colonystimulating factor. Proc Natl Acad Sci USA 1986;83:7633-7637
34. Nicola NA, Begley CG, Metcalf D. Identification of the human analogue of a regulator that induces differentiation in murine leukemia cells. Nature 1985;314:625-628
35. Welte K, Bonilla MA, Gillio AP, Boone TC, Potter GK, Gabrilove JL, et al. Recombinant human granulocyte colonystimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med 1987;165:941-948
36. Metcalf D. The molecular control of cell division, differentiation, commitment and maturation in haematopoietic cells. Nature 1989;339:27-30.
37. Hadaya K, Kared H, Masson A, Chatenoud L, Zavala F. G-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouse. J Autoimmun 2005;24:125-134
38. Mielcarek M, Martin PJ, Torok-Storb B. Suppression of alloantigen- induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 1997;89:1629-1634
39. Rutella S, Rumi C, Lucia MB, Sica S, Cauda R, Leone G. Serum of healthy donors receiving recombinant human granulocyte colonystimulating factor induces T cell unresponsiveness. Exp Hematol 1998;26:1024-1033
40. Kared H, Masson A, Adle-Biasette H, Bach JF, Chatenoud L, Zavala F. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4+CD25+ regulatory T cells. Diabetes 2005;54:78-84.
41. Rutella S, Bonanno G, Pierelli L, Mariotti A, Capoluongo E, Contemi AM, et al. Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-a. Eur J Immunol 2004;34:1291-1302
42. Rutella S, Zavala F, Danese S, Kared H, Leone G. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J Immunol 2005;175:7085-7091
43. Pan L, Delmonte J Jr, Jalonen CK, Ferrara JL. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1995;86:4422-4429
44. Sloand EM, Kim S, Maciejewski JP, Van Rhee F, Chaudhuri A, et al. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 2000;95:2269-2274
45. Boneberg EM, Hareng L, Gantner F, Wendel A, Hartung T. Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma. Blood 2000;95:270-276
46. Hartung T, Docke WD, Gantner F, Krieger G, Sauer A, Stevens P, et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 1995;85:2482-2489
47. Solaroglu I, Cahill J, Jadhav V, Zhang JH. A novel neuroprotectant granulocyte-colony stimulating factor. Stroke 2006;37:1123-1128
48. Schabitz WR, Kollmar R, Schwaninger M, Juettler E, Bardutzky J, Scholzke MN, et al. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 2003;34:745-751